Who is Running DCTs?

Decentralized Clinical Trials (DCTs) have emerged as a transformative approach in clinical research, offering increased patient accessibility, improved recruitment, and enhanced data collection. As this model gains traction, a crucial question arises: Who is at the helm of these innovative trials? The landscape of DCT leadership is diverse, ranging from traditional pharmaceutical companies and contract research organizations (CROs) to specialized DCT providers and tech-enabled clinical trial platforms.

Join us to discuss:

How are traditional roles in clinical trial management evolving with the rise of DCTs, and what new players are emerging in this space?

What unique challenges and advantages do different types of organizations (pharma, CROs, tech companies) bring to DCT management?

How might the changing landscape of DCT leadership impact trial design, patient experience, and data quality in the coming years?